Urban particulate matter (UPM) air pollution and vitamin D deficiency are detrimentally associated with respiratory health. This is hypothesized to be due in part to regulation of IL-17A, which UPM is reported to promote. Here, we used a myeloid dendritic cell (DC)-memory CD4
1 IFN-g 1 cells, most prominently when DCs were co-treated with the corticosteroid dexamethasone, while maintaining antiinflammatory IL-10 synthesis. These data indicate that UPM might promote an inflammatory milieu in part by inducing an IL-23-driven proinflammatory Th17 response. Restoring vitamin D sufficiency may counteract these UPM-driven effects without obliterating important homeostatic immune functions.
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Clinical Relevance
Urban particulate matter air pollution and vitamin D deficiency are both detrimentally associated with airway function. This research describes an IL-23-dependent pathway by which urban particulate matter promotes a proinflammatory T helper 17 cell response, which is predicted to exacerbate respiratory diseases, and the capacity of vitamin D to oppose this effect. This supports the concept that restoring vitamin D sufficiency will help to counteract the detrimental properties of air pollution to maintain immune homeostasis.
Asthma is a complex and heterogeneous disease that is estimated to affect more than 300 million people worldwide. It is typically well controlled with b2-receptor agonists and corticosteroids. However, 5-10% of asthmatics have particularly poorly controlled severe disease that is frequently associated with a neutrophilic infiltrate alongside elevated levels of IL-17A, the prototypical cytokine of T helper 17 (Th17) cells, throughout the airways (1) . Chronic obstructive pulmonary disease (COPD), another respiratory disease that is predicted to be the third leading cause of mortality by 2020, is also characterized by elevated levels of IL-17A in the bronchial submucosa and peripheral blood (2) . Homeostatically, Th17 cells are nevertheless essential for protection against bacteria and fungi such as Klebsiella pneumoniae and Candida albicans at mucosal surfaces.
Th17 cells are not a homogeneous population, and a subset of proinflammatory Th17.1 cells has been described that drives experimental autoimmune encephalomyelitis in mice (3, 4) . Upon T cell receptor stimulation, Th17.1 cells differentiate in the presence of IL-23 to co-express the Th17-associated cytokines IL-17A, IL-17F, and IL-22 with Th1-associated IFN-g, but not the antiinflammatory mediator IL-10. Zielinski and colleagues showed that human C. albicans-specific Th17 cells produced both IL-17A and IFN-g, but not IL-10, upon restimulation (5) . Beyond Th1 and Th17 cytokines, the pathogenicity of IL-23-driven Th17 cells appears to be dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF), such that in the absence of GM-CSF, autoimmune neuroinflammation does not develop in mice (6, 7) . Ramesh and colleagues further phenotyped human proinflammatory Th17.1 cells by culturing CD4
1 T cells in the presence of anti-CD3, anti-CD28, and IL-23 (8) . These cells were identified as
, transiently expressing c-Kit and stably expressing multi-drug resistance type 1 (MDR1). This is of interest because levels of both IL-17A and IFN-g are heightened in severe and steroid refractory asthma (9) (10) (11) , and MDR1
1 proinflammatory Th17 cells were found to be refractory to a range of corticosteroids (8) .
The increase in the prevalence of chronic respiratory diseases over recent decades highlights a key role for environmental factors in disease development and progression (12) . In particular, there is a substantial body of epidemiological data that detrimentally link both poor air quality and vitamin D deficiency to asthma and COPD (13, 14) . Exposure to elevated concentrations of ambient particulate matter (PM) has been associated with asthma exacerbations as well as increased hospitalization and medication usage, with emerging evidence supporting a role in the initiation of asthma (15) . Importantly, previous epidemiological studies have shown that air pollutiontriggered asthma exacerbations occur with a 2-to 5-day lag, suggesting that the pollution itself may play an indirect role, possibly by perturbing lymphocyte responses rather than by directly inducing bronchoconstriction or immediately triggering innate immune responses (16) . Consistent with this view, a reduction in PM-induced airway hyperresponsiveness and mucus cell hyperplasia was reported in Rag1 2/2 mice that lack lymphocytes (17) .
Vitamin D deficiency has also been associated with the increased incidence and severity of many respiratory diseases, including asthma, as reviewed in detail elsewhere (14, 18) . The majority of vitamin D is generated when UV-B radiation photolyses 7-dehydrocholesterol in the skin into vitamin D 3 . Vitamin D 3 can then be converted into the active form of vitamin D, namely, 1,25(OH) 2 D 3 , by the enzyme CYP27B1, which is present in the kidneys and various peripheral immune cells. Although statistically significant associations between respiratory diseases and both air pollution and vitamin D deficiency have been reported (as discussed above), the underlying molecular mechanisms by which these environmental factors influence pathophysiology are not fully understood. Furthermore, although it has been proposed that vitamin D may counteract the detrimental effects of UPM, how it achieves this remains to be fully elucidated.
In vivo, the inhaled PM and desorbed components are presented to the immune system in part by interdigitating myeloid dendritic cells (DCs) that line the airways and lung parenchyma. The DCs can then traffic to the mesenteric lymph node and modulate effector T cell function, or can act more locally to promote airway inflammation (19) . Whereas UPM has been reported to promote the maturation of DCs (19) , vitamin D has been shown independently to have the opposite effect, acting to promote a tolerogenic DC phenotype (20) . Within the lung, memory CD4 1 T cells are extremely abundant and therefore any modulation of these cells by UPM-primed DCs may play an important role in air pollution-induced disease exacerbations (21) , an issue that we sought to address in the current study.
In this study, we aimed to phenotype the cytokine profile of human memory CD4
1 IL-17A 1 T cells generated after co-culture with UPM-pretreated CD1c 
Cell Proliferation
Before culturing, T cells were labeled with 5 mM CellTrace Violet (ThermoFisher). Cell proliferation was assessed on Day 7 of co-culture by loss of fluorescence intensity.
Intracellular Cytokine Staining
Cells were stimulated at 37 8 C with 50 ng/ml phorbol myristate acetate and 500 ng/ml ionomycin for 1 hour, and 2 mM monensin was added for a further 4 hours. Cells were surface stained with CD4-PerCP (SK3; BD Biosciences) and Zombie Aqua (BioLegend) 6 CD161-BV412 (DX12; BD Biosciences) and MDR1-PerCPeFluor710 (UIC2; eBioscience) before they were fixed and permeabilized (Fix/Perm kit; BD Biosciences). Samples were then incubated with the following antibodies: IL-17A-APC and IL-22-eFluor450 (eBio64DEC17 and 22URTI, respectively; eBioscience); IFN-g-FITC, GM-CSF-PE, IL-10-PE, IL-13-PE, and granzyme B Alexa Fluor 700 (4S.B3, BVD2-21C11, JES3-9D7, JES10-5A2, and GB-11, respectively; BD Biosciences); and IL-17F Alexa Fluor 488 and TNF-a-FITC (Poly5166 and MAb11, respectively; BioLegend).
Cytometric Bead Array
Cytometric bead array (BD Biosciences) was employed to measure the concentration of cytokines within supernatants in accordance with the manufacturer's instructions.
qRT-PCR
RNA was isolated from Qiazol-lysed cells using an miRNeasy Mini Kit (Qiagen, Crawley, UK). mRNA was converted to cDNA by using RevertAid Reverse Transcriptase and complementary reagents. qRT-PCR was performed in triplicate on a ViiA7 system using TaqMan probes (ThermoFisher).
Data Analysis
Flow-cytometry data were analyzed using FlowJo (Treestar Inc., version 10). Cumulative data were analyzed using Graphpad Prism version 6.00 for Windows. After the data were assessed for a Gaussian distribution, statistical analyses were performed as outlined in the figure legends. and CD11b 1 DCs that line the airways and lung parenchyma, respectively (24) . Considering that both air pollution and vitamin D deficiency are associated with the incidence and severity of respiratory diseases, the impact of these factors on CD1c
1 DC maturation and downstream memory T cell responses was investigated. CD1c
1 DCs were cultured for 20 hours in the presence of the indicated concentration of 1,25(OH) 2 D 3 and/or a reference source of UPM (NIST SRM-1648a, referred to as NIST), added at a concentration (5 mg/ml) that was determined to consistently stimulate DC maturation both here ( Figure  E1A in the online supplement) and in a previous study (25) . rhGM-CSF (50 ng/ml) was added to all DC cultures as a substitute for the rhGM-CSF released by UPM-stimulated human bronchial epithelial cells (26, 27) , an approach that was previously shown to enhance the CD1c 1 DC maturation induced by NIST (28) . Figure 1A shows a magnified image of DCs clumping around the NIST particle agglomerates after 20 hours in culture, in contrast to the resting cells cultured in the presence of 3% methanol VC. DC surface staining was performed, and both representative histograms and cumulative data are shown ( Figures 1B and 1C) . The VC did not modulate expression of the surface markers assessed, but there was a 1,25(OH) 2 D3 dose-dependent downregulation in expression of CD40, CD83, and HLA-DR. This occurred alongside an upregulation in expression of the inhibitory receptor immunoglobulin-like transcript 3 (ILT3), as previously independently reported (29), but not of the ILT1, ILT2, or ILT4 molecules ( Figure E2A ).
In contrast, NIST dose-dependently increased expression of the maturation marker CD83 at the mRNA and protein level ( Figure E1A ), such that expression was significantly enhanced relative to both the VC and 1,25(OH) 2 D3 conditions (P , 0.01; Figure 1C ). There was also a trend toward increased expression of the lymph node-homing receptor CCR7 on the NISTtreated DCs ( Figure E2A ). Expression of HLA-DR, CD40, and ILT3 was not consistently modulated by NIST treatment. Addition of 1,25(OH) 2 D3 to the culture with NIST significantly reduced expression of CD83 (P , 0.01) and CD40 (P , 0.05) relative to the NIST-only condition, whereas expression of ILT3 remained significantly elevated (P , 0.05; Figure 1C) . Similarly, levels of IL-6 (P , 0.01) and TNF-a (P = 0.17) were elevated in NIST-treated DC culture supernatants after 20 hours ( Figure  E2B ). In support of this, mRNA expression of il6 was dose-dependently elevated in NIST-primed DCs ( Figure E1B ). Treatment of CD1a
1 DCs derived from nasal turbinates with NIST modestly increased expression of CD40 and CCR7 in a small sample size, and there was a trend toward elevated levels of IL-6 in cell culture supernatants (P = 0.0531; Figures E2C and E2D ). 1,25(OH) 2 D3 alone had no effect, but appeared to counteract the elevated expression of CD40 and CCR7 as well as the augmented levels of IL-6 when added in combination with NIST. (Figures 2A and 2B) . Notably, the frequency of memory CD4 1 T cells coexpressing IL-17A with IFN-g, GM-CSF, or granzyme B was significantly elevated in the NIST condition as compared with the VC when shown as a percentage of all memory CD4
1 T cells ( Figure 2C ), or as a percentage of total memory CD4
1 IL-17A 1 cells that co-expressed the indicated cytokine (D) (n = 5-7 except for IL-17A and IFN-g [n = 21 and 16, respectively]). Data were assessed by paired t test comparing the vehicle and NIST; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Results from analysis of secreted cytokines present in the culture supernatants reflected those obtained by intracellular cytokine staining ( Figure 3C ), with levels of IL-17A, IL-17F, IL-12/23p40, and IFN-g being consistently elevated in the NIST-treated condition and reduced by co-incubation of DCs with 1,25(OH) 2 D 3 . Levels of IL-13 and IL-10 were variable and not consistently modulated by 1,25 (OH) 2 D 3 and/or NIST. In addition to cytokines, NIST-primed DCs also increased T cell surface expression of the lectin-like receptor CD161, which was opposed by 1,25(OH) 2 D 3 , with a more modest effect on expression of MDR1 ( Figure 3D) ; both of these markers have been associated with Th17.1 cells in humans (8) . The mRNA expression of relevant Th17-associated transcription factors was additionally screened after 48 hours of co-culture (data shown in Figure E3B ). There was a trend toward increased expression of stat3, tbx21, mdr1, and irf4 in the NIST condition, with 1,25(OH) 2 D 3 treatment opposing this effect (P , 0.05 for stat3, mdr1, and irf4; P = 0.073 for tbx21). Figure 5A ). Of note, il12 mRNA expression in DCs was undetectable by qRT-PCR ( Figure E1C) . A neutralizing antibody specific for IL-23p19 (which would thus inhibit IL-23, but not IL-12) or a relevant isotype control was then added throughout the culture period. As Figure 5B shows, NIST-primed DCs significantly increased expression of il17a and mdr1 mRNA after 48 hours of co-culture in the isotype condition, in agreement with the protein data in Figure 3 , but this was significantly reduced by addition of anti-IL-23 into the culture, whereas expression of il10 was unaffected. Similarly, at the protein level, although anti-IL-23p19 had no effect on NIST-driven cell division, it significantly reduced the frequency of IL-17A 
Discussion
The current study demonstrates that pretreatment of human myeloid DCs with a common reference source of UPM (NIST) alters their maturation state, resulting in the expansion of a population of memory CD4 1 T cells possessing a proinflammatory Th17.1-like phenotype. These cells are characterized by the co-expression of IL-17A with IFN-g, GM-CSF, and granzyme B, and are predicted to drive exacerbations of respiratory diseases. Our data indicate a central role for NIST-induced IL-23 synthesis by myeloid DC in driving this proinflammatory Th17 response. An additional novel feature of these data is the evidence that UPM significantly increased expression of GM-CSF and the serine protease granzyme B, specifically enriching the proportion of cells that co-expressed these cytokines with IL-17A (Figure 2 ). Granzyme B can be released from the granules of cytotoxic T cells and is traditionally thought of as mediating apoptosis of target cells, but it can also stimulate proinflammatory cytokine release and drive extracellular matrix remodeling (32) . To date, co-expression of IL-17A and granzyme B by CD4 1 T cells has been implicated predominantly in neuroinflammation (33) , but elevated levels of granzyme B have been associated with various diseases, including autoimmune conditions, type I diabetes, and asthma. Collectively, these data suggest that UPM, via actions on the antigen-presenting-cell compartment, promotes a Th17 population with a potentially pathogenic phenotype.
In contrast to the effects of NIST, vitamin D reduced both CD1c
1 DC priming and the subsequent proinflammatory memory T cell response when added alone and in combination with NIST, and instead promoted a more tolerogenic phenotype (Figure 1) . Although the individual effects of NIST (19) 1 T cells were added for a further 5 days and then supernatants were harvested for cytometric bead array (C; n = 6). (B) Cells were expanded with 10 U/ml IL-2 for 2 days, stimulated for 5 hours with PMA and ionomycin, and then assessed for intracellular cytokine expression (n = 5). Data were assessed by two-way ANOVA with Sidak's multiple-comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. On Day 5 of co-culture, supernatants were harvested and the cells were expanded with 10 U/ml IL-2 for a further 2 days. They were then stimulated for 5 hours with PMA and ionomycin, and assessed for intracellular cytokine expression. Shown are representative plots (C) and cumulative data (D) (n = 8; data assessed by a two-tailed paired t-test, **P = 0.01; ***P < 0.001). Iso, isotype; Rorc, the transcription factor retinoic acid receptor related orphan receptor C.
these two environmental factors co-exist. Furthermore, the synthetic corticosteroid dexamethasone was similarly capable of reducing the expression of NIST-driven maturation markers on CD1c 1 DCs, both alone and more prominently when added in combination with 1,25(OH) 2 D3 (Figure 4) Figure E3 ). These results might help to explain previous observations: for example, one study reported that vitamin D-insufficient children in Puerto Rico living close to a major road, and therefore to traffic-related air pollution, have an elevated risk of severe asthma exacerbations (34) . Notably, in the European Study of Cohorts for Air Pollution Effects, the relative effect of air pollution on health outcomes differed between cohorts, with Scandinavian groups often being more sensitive despite having lower levels of ambient PM (35) . This may be due to geographical differences in PM composition and/or intrinsic variations in population, which warrant further study. For example, reduced UVR exposure in Scandinavian countries would lower circulating levels of vitamin D, which, as we show here, counteracts certain potentially pathogenic properties of PM.
The fact that priming DCs with a source of UPM increased the frequency of IL-17A 1 cells concurs with previous studies in mice (31, 36) and humans (25, 31, 37) that identified links between air pollution and IL-17A, albeit in distinct experimental settings. However, in this study, we extend that observation to show that NIST-primed DCs also enhanced the frequency of cells expressing Th17-associated cytokines IL-17F and IL-22, as well as IFN-g, GM-CSF, and granzyme B. Critically, a large proportion of the NIST-driven IL-17A 1 cells in this study co-expressed IL-17F, IL-22, IFN-g, GM-CSF, and granzyme B, but not immunoregulatory IL-10 ( Figure 2 ), a phenotype that is indicative of a putatively pathogenic Th17 cell (Th17.1) (3, 4, 6, 7) . Furthermore, NIST-primed DCs increased T cell expression of MDR1 and CD161 in co-culture ( Figure 3D ), both of which have been associated with a proinflammatory Th17 phenotype in humans (8) . This subset of Th17 cells has been shown to drive autoimmune conditions in a GM-CSF-dependent manner in mice; however, their functional role and in vivo existence in humans is less clear. Although Th17/Th1 cells have been identified in humans, predominantly in the periphery, inflamed joints, and the gut (5, 8, 38) , functional analyses and detailed phenotyping of these cells have been understandably limited to date.
However, production of both IL-17A and IFN-g was shown to correlate inversely with lung function after corticosteroid therapy in steroid-refractory asthmatics (39) , and GM-CSF was found to be elevated even during the asymptomatic stage of asthma (40) . Moreover, proinflammatory MDR1
1 human Th17 cells reportedly are resistant to a range of corticosteroids (8), a characteristic of both severe asthma and COPD as well as various autoimmune conditions. Recently, a study performed using the murine house dust mite model of asthma found that both dexamethasone and anti-IL-17A were required to alleviate diesel exhaust particle-induced corticosteroidrefractory asthma (41) . However, we observed that when we used the in vitro co-culture system described here, priming of CD1c
1 DCs from healthy donors in the presence of dexamethasone dampened the resultant NIST-driven proliferation and IL-17A/IFN-g memory CD4
1 T cell profile response, with no effect on the levels of IL-10 ( Figure 4 ). This conforms with data showing that dexamethasone-treated, monocyte-derived DCs possess a stable tolerogenic phenotype (42) . Nonetheless, using various in vitro and ex vivo experimental systems, both our group (9, 39) and others (43) observed that corticosteroids acting directly on human T cells failed to inhibit IL-17A production and enhanced levels of IL-10, highlighting the importance of the context in which corticosteroids are administered.
Considering the phenotype of the NIST-driven IL-17A 1 cells and the fact that il23 mRNA expression was significantly upregulated in DCs alongside enhanced levels of IL-12/23p40 in culture supernatants, we hypothesized that NIST acts via enhanced IL-23 activity to promote the proinflammatory Th17 response. Indeed, specific neutralization of IL-23 impaired the NIST-driven IL-17A and IFN-g response while maintaining levels of IL-10 and not affecting cell proliferation, most significantly targeting IL-17A
1 IFN-g 1 cells ( Figure 5 DCs with NIST increased IL-23 synthesis, driving a phenotypically proinflammatory and potentially pathogenic Th17 profile. However, addition of active vitamin D, alone or in combination with corticosteroids, was able to counteract some of the effects of NIST while maintaining the levels of IL-10, supporting the notion that restoring vitamin D sufficiency may help to control inflammatory diseases and counteract certain negative effects of air pollution. This might be particularly true in subgroups of individuals, such as vitamin D-deficient individuals and those who are regularly exposed to high levels of air pollution. n Author disclosures are available with the text of this article at www.atsjournals.org.
